RESULTS Case-control study As shown in Table 1, the BMIs of the obese and Control Groups were 25.6 1.4 kg/m 2 and 20.9 1.2 kg/m 2 , respectively
Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo
Through a retrospective review of cutaneous adverse events associated with semaglutide, dulaglutide, tirzepatide, lixisenatide, liraglutide, and exenatide in the FDA Adverse Event Reporting System, it was found that the 5 most common cutaneous reactions associated with GLP-1 agonists were eczematous, pruritus, drug eruptions, hyperhidrosis, and alopecia
This was calculated from ~232 lb starting weight.* *In a supportive measure, at week 68, at least 20% weight loss was seen in 30% of people taking Wegovy versus 2% of people taking placebo
doi: 10.1016/J.METABOL.2020.154304 35 NatalicchioALabarbutaRTortosaFBiondiGMarranoNPeschecheraAet al